Clinical Trial Update: AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson's Disease After Immunization With AFFITOPE® PD01A

View source ↗

Summary

This update reports the completion of AFF008E, an observational Phase 1b follow-up extension study of Parkinson's disease patients immunized with AFFITOPE PD01A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• AFFITOPE PD01A (PD01A)

Snippet

Sponsor: Affiris AG | Conditions: Parkinson's Disease | Status: COMPLETED